bioAffinity Technologies Gross Margin Growth & History (BIAF)
bioAffinity Technologies's gross margin was 30.53% for fiscal 2025.
View full bioAffinity Technologies company overviewbioAffinity Technologies annual gross margin history
2022
2023
2024
2025
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 30.53% | −5.56 pp |
| 2024 | 2024-12-31 | 36.09% | +4.83 pp |
| 2023 | 2023-12-31 | 31.26% | −59.02 pp |
| 2022 | 2022-12-31 | 90.28% | — |
bioAffinity Technologies quarterly gross margin
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 27.99% | +8.07 pp |
| Q1 2026 | 2026-03-31 | 31.29% | +5.08 pp |
| Q4 2025 | 2025-12-31 | 40.10% | — |
| Q3 2025 | 2025-09-30 | 34.84% | — |
| Q2 2025 | 2025-06-30 | 19.92% | — |
| Q1 2025 | 2025-03-31 | 26.21% | — |
| Q3 2023 | 2023-09-30 | 74.97% | −12.33 pp |
| Q2 2023 | 2023-06-30 | 93.75% | +4.93 pp |
| Q1 2023 | 2023-03-31 | 90.55% | — |
| Q3 2022 | 2022-09-30 | 87.30% | — |
| Q2 2022 | 2022-06-30 | 88.82% | — |
bioAffinity Technologies gross margin trends
Between the periods ended 2022-12-31 and 2025-12-31, bioAffinity Technologies's gross margin decreased from 90.28% to 30.53%, a change of −59.75 percentage points. The latest reported quarter, Q2 2026, shows 27.99%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review bioAffinity Technologies source filings ↗